First Drug That Protects Against Chemo-Induced Myelosuppression
A novel drug that offers multilineage protection from chemotherapy-induced myelosuppression has been approved by the
Small Cell Lung Cancer
FDA approves drug to reduce frequency of chemotherapy-induced bone marrow suppression
Today, the U.S. Food and Drug Administration approved Cosela (trilaciclib) as the first therapy in